Postdoctoral Trainees

Carlos Henrique Alves Jesus

CANNABIDIOL ATTENUATES CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHIC PAIN THROUGH A MECHANISM THAT REQUIRES THE ENZYME N-ACYL PHOSPHATIDYLETHANOLAMINE-SPECIFIC PHOSPHOLIPASE D (NAPE-PLD)

Laura Boullon

SEX-SPECIFIC REGULATION OF OPIOID-INDUCED ADAPTATION BY MICROGLIAL CB2

Michaela Dvorakova

Alisha Eversole

IMPACT OF CANNABIS USE FREQUENCY ON THE ANALGESIC EFFECTS OF SMOKED CANNABIS

Michael Ippolito

KLS 13019: A SYNTHETIC CBD ANALOGUE THAT REVERSES SYMPTOMS AND PRESERVES CHEMOTHERAPEUTIC EFFICACY IN NOVEL TRANSLATIONAL MODELS OF CIPN

Rodrigo Klein

ADOLESCENT THC EXPOSURE INDUCES A MONOCYTE PHENOTYPE PRIMED FOR ENHANCED IMMUNE RESPONSE LATER IN LIFE

Elisa Pabon

DELTA-9-TETRAHYDROCANNABINOL-SPARING EFFECTS OF CANNABIGEROL: A PLACEBO-CONTROLLED HUMAN LABORATORY STUDY

Halle Thomas

IMPACTS OF CO-ADMINISTERED ALCOHOL AND VAPORIZED CANNABIS ON SIMULATED DRIVING ABILITY AND ABUSE LIABILITY

Eva Wisniewski

MAGL INHIBITION SUPPRESSES PSORIASIFORM INFLAMMATION VIA CB2

Predoctoral Trainees 

Maria Jaakson

REPEATED MONOACYLGLYCEROL LIPASE INHIBITION REDUCES ALLODYNIA IN A MOUSE MODEL OF OPIOID-INDUCED HYPERALGESIA

Erika Lutz

EXAMINING THE PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF CANNABIGEROL (CBG) IN A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER CLINICAL TRIAL

Kaitlyn Partridge

DIFFERENTIAL REGULATION OF ERK1/2 AND MKP-3 BY JWH-133 AND 2-AG REVEALS LIGAND-BIASED CANNABINOID TYPE 2 RECEPTOR SIGNALING IN MICROGLIA

Matteya Proctor

IMPACTS OF MINOR CANNABINOIDS AND TERPENES ON MENOPAUSE AND PERIMENOPAUSE SYMPTOMS

Antonio Reck

THC-INDUCED BEHAVIOR, PHYSIOLOGY, AND WITHDRAWAL EFFECTS ARE EXACERBATED BY RGS12 DELETION

Michael Taylor

MONOACYLGYCEROL LIPASE AS A POTENTIAL BIOMARKER AND THERAPEUTIC TARGET FOR SICKLE CELL DISEASE PAIN

Jonah Wirt

DUALSTERIC CB1 POSITIVE ALLOSTERIC MODULATOR/CB2 AGONIST GAT1102 DISPLAYS BROAD SPECTRUM ANALGESIC EFFICACY WITHOUT PRODUCING CANNABIMIMETIC EFFECTS